SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-17-067928
Filing Date
2017-03-02
Accepted
2017-03-02 17:10:55
Documents
3
Group Members
FORBION I MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D d321671dsc13d.htm SC 13D 63190
2 EX-99.1 d321671dex991.htm EX-99.1 4226
3 EX-99.2 d321671dex992.htm EX-99.2 34987
  Complete submission text file 0001193125-17-067928.txt   103877
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88006 | Film No.: 17659991
SIC: 2834 Pharmaceutical Preparations

Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 31 35 6993000
ForArgos B.V. (Filed by) CIK: 0001669166 (see all company filings)

IRS No.: 000000000
Type: SC 13D